Spinocerebellar Ataxias Clinical Trial
Official title:
Use of a New Smartphone Application, iBlink, to Determine Changes in Eyeblink Conditioning From Home Training in Individuals With Spinocerebellar Ataxias
The goal of this project is to evaluate how aerobic training impacts eyeblink conditioning as a proxy for cerebellar dependent motor learning. The newly developed smartphone application, iBlink, will be used to test participants at home in an effort to improve recruitment and increase the sample size of the study. The investigators hypothesize that aerobic training, but not balance training, will improve eyeblink conditioning in participants with spinocerebellar ataxias. The current study focuses on Aim 3 of this project.
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | September 1, 2026 |
Est. primary completion date | June 1, 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Diagnosed with spinocerebellar ataxia - Cerebellar atrophy on MRI - Prevalence of ataxia on clinical exam - Ability to safely ride a stationary exercise bike Exclusion Criteria: - Other neurologic conditions - Heart disease - Cognitive impairment - Medical instability |
Country | Name | City | State |
---|---|---|---|
United States | Columbia University/New York Presbyterian | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Columbia University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Conditioned Response (CR) Amplitude | Individual eyelid traces will be normalized by dividing each trace by the maximum signal amplitude of the relevant session. Thus, eyes closed will correspond to a value of 1, and eyes open to a value of 0. A mean baseline Conditioned Response (CR) amplitude will be determined for each participant using the pre-block Conditioned Stimulus (CS) only trials. CR amplitude will then be determined as the maximum signal amplitude value at 430ms, for paired and CS only trials, minus the baseline CR amplitude. | 0, 3, 6, and 9 months | |
Secondary | SARAhome Score | Scale for the Assessment and Rating of Ataxia Home (SARAhome) is a validated home measurement of ataxia symptoms with the participants recording 5 tasks (gait, stance, speech, nose-finger test, and fast alternating hand movements) with a smartphone. Scores range from 0 to 28 with higher scores indicating more ataxia symptoms. SARAhome and the conventional SARA were shown to be highly correlated, and this measurement was deemed reliable for home monitoring of ataxia symptoms. Scores will be used to correlate with changes in eyeblink conditioning as a result of training. | 0, 3, 6, and 9 months | |
Secondary | PROM of Ataxia Score | The Patient Reported Outcome Measure (PROM) of Ataxia is a 70-item survey that is scored by participants on a 0-4 Likert scale. It asks participants to rate motor domains of gait, lower and upper extremity control, manual dexterity, visual motor control, dysphagia, bowel and bladder function, sleep, fatigue, vertigo, libido, neuropathy, ability to do household chores, driving, self-care, mood, anxiety, motivation, and social interactions. Scores will be used to correlate with changes in eyeblink conditioning as a result of training. Scores range from 0-280 with a higher score indicating a worse outcome. | 0, 3, 6, and 9 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05973019 -
rTMS Improves Functions in Spinocerebellar Ataxia
|
N/A | |
Completed |
NCT04837027 -
Effect of Training on Brain Volume in Ataxia
|
N/A | |
Completed |
NCT04595578 -
Cerebellar rTMS and Physical Therapy for Cerebellar Ataxia
|
N/A | |
Completed |
NCT03745248 -
Aerobic Exercise, Balance Training, and Ataxia
|
N/A | |
Completed |
NCT05951010 -
Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia 38
|
N/A | |
Completed |
NCT01037777 -
RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7
|
||
Completed |
NCT00136630 -
Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations
|
||
Completed |
NCT03687190 -
Could Tai-chi Help Maintain Balance of Spinocerebellar Ataxia Patients
|
N/A | |
Active, not recruiting |
NCT03701399 -
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
|
Phase 3 | |
Completed |
NCT05436262 -
Using Real-time fMRI Neurofeedback and Motor Imagery to Enhance Motor Timing and Precision in Cerebellar Ataxia
|
N/A | |
Recruiting |
NCT04231487 -
Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
|
||
Withdrawn |
NCT04301284 -
Study of CAD-1883 for Spinocerebellar Ataxia
|
Phase 2 | |
Not yet recruiting |
NCT06397274 -
Stemchymal® for Polyglutamine Spinocerebellar Ataxia
|
Phase 2 | |
Recruiting |
NCT04529252 -
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
|
||
Completed |
NCT05621200 -
Transcranial Alternating Current Stimulation (tACS) in Patients With Ataxia
|
N/A | |
Completed |
NCT03701776 -
Ataxia and Exercise Disease Using MRI and Gait Analysis
|
N/A | |
Completed |
NCT03120013 -
Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia
|
N/A | |
Active, not recruiting |
NCT03408080 -
Open Pilot Trial of BHV-4157
|
Phase 3 | |
Active, not recruiting |
NCT02960893 -
Trial in Adult Subjects With Spinocerebellar Ataxia
|
Phase 2/Phase 3 | |
Completed |
NCT04153110 -
Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia
|
N/A |